Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Sanofi SA (SANp)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
89.37 -0.35    -0.39%
16:29:44 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 1,430
  • Bid/Ask: 89.01 / 0.00
  • Day's Range: 89.08 - 90.00
Type:  Equity
Market:  Euro Zone
ISIN:  FR0000120578 
Sanofi 89.37 -0.35 -0.39%

SANp Income Statement & Profits

 
Assess the Sanofi SA income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Revenue 11118 11790 12698 10588
Revenue 10464 10919 11964 9965
Other Revenue, Total 654 871 734 623
Cost of Revenue, Total 3439 4028 3841 3263
Gross Profit 7679 7762 8857 7325
Total Operating Expenses 9086 10975 9221 9042
Selling/General/Admin. Expenses, Total 2605 3004 2579 2616
Research & Development 1719 1872 1663 1630
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating -253 -625 -318 -60
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 1576 2071 1456 1593
Operating Income 2032 815 3477 1546
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 199 687 - 413
Other, Net 523 377 376 -585
Net Income Before Taxes 1310 -249 3101 1718
Provision for Income Taxes 164 309 563 271
Net Income After Taxes 1146 -558 2538 1447
Minority Interest - 313 - 318
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1133 -555 2525 1435
Total Extraordinary Items - - - -
Net Income 1133 -555 2525 1435
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1133 -555 2525 1435
Dilution Adjustment - -2.52 - 5.22
Diluted Net Income 1133 -552.48 2525 1429.78
Diluted Weighted Average Shares 1248.8 1253.6 1253.2 1250.6
Diluted EPS Excluding Extraordinary Items 0.907 -0.443 2.01 1.14
DPS - Common Stock Primary Issue - 3.76 - -
Diluted Normalized EPS 0.937 0.151 1.67 0.713
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SASY Price Commentary

Write your thoughts about Sanofi
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Boubacar s b Toure
Boubacar s b Toure Mar 11, 2023 1:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nzf
Oct 06, 2022 17:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will eventually do well because of French strategy. France is at the top table and Sanofi was made up by absorbing others to grow. Look at 20% in a couple of years
Greg Greg
Greg Greg Dec 11, 2020 9:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
there is no future for it
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email